Cibula D, Rob L, Mallmann P, Knapp P, et al. Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial. Gynecol Oncol 2021 Jul 19. pii: S0090-8258(21)00533.
PMID: 34294416